Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients

AIDS

Volumn 12, Issue 9, 1998, Pages 1033-1037

  Jandourek, Alena ^a   Vaishampayan, Julie K ^a   Vazquez, Jose A ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fluconazole refractory; Melaleuca oral solution; Mucosal candidiasis

Indexed keywords

ANTIFUNGAL AGENT; BREATH AWAY; FLUCONAZOLE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; FUNGUS CULTURE; HUMAN; MALE; MELALEUCA; MINIMUM INHIBITORY CONCENTRATION; MOUTHWASH; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THRUSH;

EID: 0032543639     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199809000-00011     Document Type: Article

References (16)

1. Van Meter F, Gallo JW, Garcia-Rojas G, Tan MM, Silverman S: A study of oral candidiasis in HIV-positive patients. J Dent Hyg 1994, 68:30-34.
2. Greenspan D: Treatment of oropharyngeal candidiasis in HIV-positive patients. J Am Acad Dermatol 1994, 31 (suppl):S51-S55.
3. Coker RJ, Fisher M, Tomlinson DR: Management of mycoses associated with HIV disease. Int J STD AIDS 1995 6:408-412.
4. Silverman Jr S, Gallo JW, McKnight ML, Mayer P, deSanz S, Tan MM: Clinical characteristics and management responses in 85 HIV-infected patients with oral candidiasis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996, 82:402-407.
5. Boken DJ, Swindells S, Rinaldi MG: Fluconazole-resistant Candida albicans. Clin Infect Dis 1993, 17:1018-1021.
6. White A, Goetz MB: Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review. Clin Infect Dis 1994, 19:687-692.
7. Humphrey EM: New Australian germicide. Med J Aust 1995, 30:85.
8. Feinblatt HM: Cajeput-type oil (tea tree oil) for the treatment of furunculosis. J Natl Med Assoc 1960, 52:32-34.
9. National Committee for Clinical Laboratory Standards: Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast. Proposed Standard M27-T. Villanova: National Committee for Clinical Laboratory Standards; 1995.
10. Hammer KA, Carson CF, Riley TV: Susceptibility of transient and commensal skin flora to the essential oil of Melaleuca alternifolia (tea tree oil). Am J Infect Control 1996, 24:186-189.
11. Brophy JJ, Davies NW, Southwell IA, Stiff IA, Williams LR: Chromatographic quality control for oil of Melaleuca terpinen-4-ol type (Australian tea tree). J Agric Food Chem 1989, 37:1330-1335.
12. Ramanoelina AR, Terron GP, Bianchini JP, Coulanges P: Antibacterial action of essential oils extracted from Madagascar plants. Arch Inst Pasteur Madagascar 1987, 153:217-226.
13. Carson CF, Riley TV: Antimicrobial activity of the major components of the essential oil of Melaleuca alternifolia. J Appl Bacteriol 1995, 78:264-269.
14. Nenoff P, Haustein UF, Brandt W: Antifungal activity of the essential oil of Melaleuca alternifolia (tea tree oil) against pathogenic fungi in vitro. Skin Pharmacol 1996, 9:388-394.
15. Buck DS, Nidorf DM, Addino JG: Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole. J Fam Pract 1994, 38:601-605.
16. Tong MM, Altman PM, Barnetson RS: Tea tree oil in the treatment of tinea pedis. Australas J Dermatol 1992, 33:145-149.